Premium
Characterization of idiopathic esophagogastric junction outflow obstruction
Author(s) -
van Hoeij F. B.,
Smout A. J. P. M.,
Bredenoord A. J.
Publication year - 2015
Publication title -
neurogastroenterology and motility
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.489
H-Index - 105
eISSN - 1365-2982
pISSN - 1350-1925
DOI - 10.1111/nmo.12625
Subject(s) - medicine , achalasia , dysphagia , high resolution manometry , peristalsis , etiology , gastroenterology , esophagogastric junction , surgery , esophagus , adenocarcinoma , cancer
Background Esophagogastric junction ( EGJ ) outflow obstruction is a manometric diagnosis, characterized by an elevated relaxation pressure ( IRP 4) of the lower esophageal sphincter ( LES ) and intact or weak peristalsis. The etiology and preferred treatment remain unknown. We describe a large patient cohort in detail, for a better understanding of this rare disorder. Methods We included 47 patients, diagnosed with EGJ outflow obstruction on high‐resolution manometry ( HRM ) between 2012 and December 2014. Key Results Idiopathic EGJ outflow obstruction was diagnosed in 34 patients. The majority (91%) of patients presented with retrosternal pain or dysphagia. The median ( IQR ) for various HRM parameters was IRP 4, 18.9 mmHg (18–23); intrabolus pressure ( IBP ), 8.3 mmHg (5–12) and basal LES pressure, 27.5 mmHg (22–33). Peristaltic breaks were seen in 88% and elevated IBP max in 74% of patients. No patients had stasis, difficult LES passage or esophageal dilation on endoscopy. Only 7/25 patients (28%) had stasis on barium esophagography. In 26 patients (82%), no treatment was required: 18 had symptoms judged unrelated to outflow obstruction, 5 had spontaneous symptom relief, and 3 declined therapy. Eight patients were treated: five received botox injections with a good but short‐lived effect, three received pneumatic dilatation, of which one was successful. Three patients were diagnosed with achalasia on a subsequent manometry. Conclusions & Inferences Primary EGJ outflow obstruction has an unclear clinical significance. A substantial part of patients has unrelated symptoms, spontaneous symptom relief, or no stasis. Treated patients showed a beneficial response to botox injections. A small proportion develops achalasia at follow‐up.